Prof. David Goldstein
Institute for Genomic Medicine at Columbia University Medical Center
David Goldstein, Ph.D., is the John E. Borne Professor of Genetics and Development and Director of the Institute for Genomic Medicine at Columbia University Medical Center. Previously, he was a Professor of Genetics at Duke University and the Director for the Center for Human Genome Variation. He trained in theoretical population genetics at Stanford University. Dr. Goldstein’s primary research interests include human genetic diversity, the genetics of disease, and pharmacogenetics. The Goldstein group and collaborators have discovered a number of disease causing genes and syndromes, in particular neurological and infectious diseases.
Dr. Goldstein was elected a fellow of the American Association for the Advancement of Science (AAAS) in 2013, received the University of North Carolina at Chapel Hill Institute for Pharmacogenomics and Individualized Therapy (IPIT) award for clinical services in 2012, and was a recipient of one of the first seven nationally awarded Royal Society/Wolfson research merit awards in the United Kingdom for his work in human population genetics. In 2013, Dr. Goldstein chaired the Gordon Research Conference in Human Genetics, and he is currently serving on the Advisory Council at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH).